Navigation Links
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Date:10/16/2007

d 345 patients received Zingo one to three minutes before undergoing medical procedures requiring venipuncture or IV line placement at the back of hand or antecubital fossa (crux of the elbow). The primary endpoint was pain upon needle insertion utilizing the VAS pain scale. Demographic characteristics and sites of administration were evenly distributed across treatment groups.

The mean pain score in the Zingo-treated patients was significantly lower than in the placebo group (p = 0.003). Zingo was also well tolerated. The most common skin assessment findings were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration. The incidence of adverse events with Zingo was no higher than with placebo.

About Zingo

Zingo is a ready-to-use, single-use, needle-free system that delivers sterile lidocaine powder into the skin and provides topical, local analgesia in one to three minutes after administration. This rapid onset, which may be especially useful in busy emergency room settings, means the product can be incorporated into a medical procedure allowing uninterrupted care, an important advantage over current options. In addition to the hospital setting, Zingo may be used in physicians' offices and clinical laboratories. Anesiva also intends to expand the product label beyond the pediatric population by filing an sNDA for Zingo in adults in early 2008.

About Anesiva and its Diverse Portfolio of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, to reduce pain associated with peripheral venous access procedures in children three to 18 years of age. The second product in Anesiva's pipeline, Adlea(TM) (formerly 4975), has been shown to reduce pain after only a
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... quarter ended March 31, 2015 and provided an update ... continue to make progress across our targeted oncology clinical ... president and CEO, Mirati. "We look forward to providing ... of Clinical Oncology meeting at the end of the ...
(Date:5/6/2015)... May 6, 2015 Lannett Company, Inc. (NYSE: ... fiscal 2015 third quarter ended March 31, 2015.  ... sales rose 24% to $99.4 million from $80.0 million ... to $75.6 million, or 76% of net sales, from ... development (R&D) expenses decreased to $9.2 million from $10.6 ...
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
Breaking Medicine Technology:Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2
... 11, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... medical dressings, medical disposables and non-woven fabric made from 100% natural ... second quarter ended March 31, 2011. Second Quarter ... Revenue increased by 27% over Q2 FY 2010 to ...
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... – Generics Market Overview: Patent cliff ... despite tougher market conditions ...
Cached Medicine Technology:Winner Medical Reports Second Quarter Fiscal 2011 Results 2Winner Medical Reports Second Quarter Fiscal 2011 Results 3Winner Medical Reports Second Quarter Fiscal 2011 Results 4Winner Medical Reports Second Quarter Fiscal 2011 Results 5Winner Medical Reports Second Quarter Fiscal 2011 Results 6Winner Medical Reports Second Quarter Fiscal 2011 Results 7Winner Medical Reports Second Quarter Fiscal 2011 Results 8Winner Medical Reports Second Quarter Fiscal 2011 Results 9Winner Medical Reports Second Quarter Fiscal 2011 Results 10Winner Medical Reports Second Quarter Fiscal 2011 Results 11Winner Medical Reports Second Quarter Fiscal 2011 Results 12Winner Medical Reports Second Quarter Fiscal 2011 Results 13Winner Medical Reports Second Quarter Fiscal 2011 Results 14Winner Medical Reports Second Quarter Fiscal 2011 Results 15Winner Medical Reports Second Quarter Fiscal 2011 Results 16Winner Medical Reports Second Quarter Fiscal 2011 Results 17Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 5
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... quality built chicken coop condo with a wheel kit is a ... on a pasture. By installing a wheel kit on a ... tractor that stands up to being moved around the pasture every ... to flex to uneven ground without losing its shape. It ... it will help provide the chickens with fresh foraging plots each ...
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... PA (PRWEB) May 06, 2015 TMG ... solutions to the Medicare Advantage, Medicare Part D and ... the Continuity and Resilience Team category at the BCI ... Continuity Institute to recognize the outstanding contribution of business ... the North America Region, including the USA and Canada. ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... carotene, either individually or in combination, do not appear ... among women at high risk for heart disease, according ... Archives of Internal Medicine, one of the JAMA/Archives journals. ... oxygenmay contribute to the development of cardiovascular disease, according ...
... may produce beneficial changes in the brains and immune ... article posted online today that will appear in the ... of the JAMA/Archives journals. , In patients with multiple ... that protect nerve cells in the brain and spinal ...
... be associated with a decreasing peripheral field of vision ... remains low overall, according to a report in the ... JAMA/Archives journals. , Prevention of further visual field deterioration ... as background information in the article. Previous studies reported ...
... 2007, Paying out certain types of government aid in a ... and often fatal drug binges, according to a new study ... that links the monthly arrival of disability checks with a ... by researchers at the University of California, Santa Cruz and ...
... structural damage to DNA, players in two important pathways ... scientists at The University of Texas M. D. Anderson ... , This connection between a signaling pathway crucial to ... remodeling "opens an entirely new category of targets for ...
... 2007 New research from scientists at UT Southwestern ... underscores the importance of preventing recurring acid reflux while ... can turn potentially cancerous. , In research published in ... reflux disease, particularly those with a complication of acid ...
Cached Medicine News:Health News:Antioxidants show no clear benefit against cardiovascular events, death in high-risk women 2Health News:DNA vaccine against multiple sclerosis appears safe, potentially beneficial 2Health News:Fluctuating eye pressure associated with visual field deterioration in glaucoma patients 2Health News:Disability payments may spur drug abuse 2Health News:Chromatin remodeling complex connected to DNA damage control 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 3
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
All Day Comfort for the Lower Body...
Medicine Products: